hrvatski jezikClear Cookie - decide language by browser settings

Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein

Tomić, Draško (2021) Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. [Dataset] (Unpublished)

This is the latest version of this item.

[img] Archive (TGZ) (Efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein) - Accepted Version - research data
Available under License Creative Commons Public Domain Dedication.

Download (1GB)
[img] Microsoft Word (The description of the data deposited) - Accepted Version - research data
Download (720B)

Abstract

These results were obtained using the Vini in silico model of cancer in the period from March to December 2020. The efficacy of 49 FDA-approved antiviral drugs on SARS-CoV-2 spike glycoprotein was analyzed. Based on the fact that HIV drugs showed the highest efficacy, the efficacy of their double and triple combinations was further calculated.

Item Type: Dataset
Uncontrolled Keywords: SARS-CoV-2; spike glycoprotein; FDA approved antiviral drugs; HIV drugs
Subjects: BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences > Human Genetics, Genomics and Proteomics
BIOMEDICINE AND HEALTHCARE > Pharmacy > Medical Biochemistry
BIOTECHNICAL SCIENCES > Biotechnology > Bioinformatics
Divisions: Center for Informatics and Computing
Projects:
Project titleProject leaderProject codeProject type
DATACROSS - Napredne metode i tehnologije u znanosti o podatcima i kooperativnim sustavima-DATACROSSSven Lončarić; Petrović IvanKK.01.1.1.01.009EK
Depositing User: Draško Tomić
Date Deposited: 18 Jan 2021 07:30
Last Modified: 18 Jan 2021 07:30
URI: http://fulir.irb.hr/id/eprint/6161

Available Versions of this Item

Actions (login required)

View Item View Item

Nema podataka za dohvacanje citata

Downloads

Downloads per month over past year

Contrast
Increase Font
Decrease Font
Dyslexic Font
Accessibility